Which venture capital firms got the best returns in 2024?
Find out in STAT's annual best-selling report now for a fraction of the cost.
This updated report delivers exclusive insights and a comprehensive analysis of the top-performing biotech venture capital firms. With a wealth of new data, uncover the latest trends and moves in biotech investment.
Whether you're an investor, industry professional, or simply curious about the financial dynamics of the biotech sector, this report is your essential guide to understanding the forces driving success in this high-stakes industry for $299 now through November 7th (regularly $499).
STAT Reports help business executives, researchers, consultants, and analysts navigate the ever-changing life sciences industry. Each report provides deep analysis of a particular issue in health care. Pick and purchase the reports that are most relevant to you.
No comments